Maria Elena Gelain

Prof. Maria Elena Gelain

orcid

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 June 2012 in Hematological Oncology
Verified
Journal Article
Closed access
PDF file
LMLaura Marconato
Laura Marconato
Maria Elena GelainMaria Elena Gelain
Maria Elena Gelain
SCStefano Comazzi
Stefano Comazzi

1 February 2008 in Veterinary Immunology and Immunopathology
Verified
Journal Article
Closed access
Maria Elena GelainMaria Elena Gelain
Maria Elena Gelain
MMM. Mazzilli
M. Mazzilli
Fulvio RiondatoFulvio Riondato
Fulvio Riondato
LMLaura Marconato
Laura Marconato
SCStefano Comazzi
Stefano Comazzi

1 May 2011 in The Veterinary Journal
Verified
Journal Article
Closed access
SCStefano Comazzi
Stefano Comazzi
Maria Elena GelainMaria Elena Gelain
Maria Elena Gelain

18 January 2019 in Antioxidants
Verified
Journal Article
Open access
PDF file
Monica ColittiMonica Colitti
Monica Colitti
BSBruno Stefanon
Bruno Stefanon
Gianfranco GabaiGianfranco Gabai
Gianfranco Gabai
Maria Elena GelainMaria Elena Gelain
Maria Elena Gelain
FBFederico Bonsembiante
Federico Bonsembiante
In the veterinary sector, many papers deal with the relationships between inflammation and oxidative stress. However, few studies investigate the mechanisms of action of oxidised molecules in the regulation of immune cells. Thus, authors often assume that these events, sometime leading to oxidative stress, are conserved among species. The aim of this review is to draw the state-of-the-art of the current knowledge about the role of oxidised molecules and dietary antioxidant compounds in the regulation of the immune cell functions and suggest some perspectives for future investigations in animals of veterinary interest.

1 January 2011 in Journal of Veterinary Internal Medicine
Verified
Journal Article
Open access
PDF file
SCStefano Comazzi
Stefano Comazzi
Maria Elena GelainMaria Elena Gelain
Maria Elena Gelain
Valeria MartiniValeria Martini
Valeria Martini
Fulvio RiondatoFulvio Riondato
Fulvio Riondato
BMB. Miniscalco
B. Miniscalco
MMMortarino Michele
Mortarino Michele
Background: Chronic lymphocytic leukemia (CLL) is a hematologic disorder in dogs, but studies on prognostic factors and clinical outcome are lacking. In people, several prognostic factors have been identified and currently are used to manage patients and determine therapy. Objectives: The aim of the study was to determine if the immunophenotype of neoplastic cells predicts survival in canine CLL. Design: Retrospective study. Animals: Forty-three dogs with CLL. Procedures: Records of dogs with a final diagnosis of CLL were reviewed. For each included dog, a CBC, blood smear for microscopic reevaluation, and immunophenotyping data had to be available. Data on signalment, history, clinical findings, therapy, follow-up, as well as date and cause of death were retrieved. Results: Seventeen dogs had B-CLL (CD21+), 19 had T-CLL (CD3+ CD8+), and 7 had atypical CLL (3 CD3− CD8+, 2 CD3+ CD4− CD8−, 1 CD3+ CD4+ CD8+, and 1 CD3+ CD21+). Among the variables considered, only immunophenotype was associated with survival. Dogs with T-CLL had approximately 3-fold and 19-fold higher probability of surviving than dogs with B-CLL and atypical CLL, respectively. Old dogs with B-CLL survived significantly longer than did young dogs, and anemic dogs with T-CLL survived a significantly shorter time than dogs without anemia. Conclusions: Although preliminary, results suggested that immunophenotype is useful to predict survival in dogs with CLL. Young age and anemia are associated with shorter survival in dogs with B-CLL and T-CLL, respectively.

1 August 2010 in Leukemia Research
Verified
Journal Article
Closed access
MMMortarino Michele
Mortarino Michele
GGGloria Gioia
Gloria Gioia
Maria Elena GelainMaria Elena Gelain
Maria Elena Gelain
FAF. Albonico
F. Albonico
Paola RoccabiancaPaola Roccabianca
Paola Roccabianca
SCStefano Comazzi
Stefano Comazzi